Method of determining human acid glutathione S-transferase, reagent,
therefor, kit therefor, method of diagnosing cancer in digestive
organs, and monoclonal antibody for use therein
    1.
    发明授权
    Method of determining human acid glutathione S-transferase, reagent, therefor, kit therefor, method of diagnosing cancer in digestive organs, and monoclonal antibody for use therein 失效
    确定人酸谷胱甘肽S-转移酶的方法,其试剂,用于其的试剂盒,消化器官中的癌症诊断方法和用于其中的单克隆抗体

    公开(公告)号:US5427917A

    公开(公告)日:1995-06-27

    申请号:US169963

    申请日:1993-12-20

    IPC分类号: C07K16/30 C07K16/40 G01N33/53

    摘要: A method of immunologically determining human acid glutathione S-transferase in a human assay sample, which comprises bringing the assay sample into contact with a first antibody bound to an insoluble solid carrier and a labelled second antibody, either the first or second antibody being a polyclonal antibody capable of recognizing human acid glutathione S-transferase or an equivalent fragment of the polyclonal antibody, and the other antibody being a monoclonal antibody capable of specifically recognizing human acid glutathione S-transferase or an equivalent fragment of the monoclonal antibody, a method of diagnosing cancer in a human digestive organ by using the above method, a reagent therefor, a kit therefor and a monoclonal antibody for use therein.

    摘要翻译: 一种在人测定样品中免疫测定人酸谷胱甘肽S-转移酶的方法,其包括使测定样品与结合于不溶性固体载体和标记的第二抗体的第一抗体接触,所述第一或第二抗体是多克隆 能够识别人酸谷胱甘肽S-转移酶或多克隆抗体的等同片段的抗体,另一抗体是能够特异性识别人酸谷胱甘肽S-转移酶或单克隆抗体的等同片段的单克隆抗体,诊断方法 通过使用上述方法的人类消化器官中的癌症,其试剂,用于其的试剂盒和用于其中的单克隆抗体。

    Immunoassay and reagent kit used therefor
    2.
    发明授权
    Immunoassay and reagent kit used therefor 失效
    用于此的免疫测定和试剂盒

    公开(公告)号:US5366861A

    公开(公告)日:1994-11-22

    申请号:US26110

    申请日:1993-03-01

    摘要: An immunoassay method performed in solution wherein a protein having an average molecular weight of 16,000 to 50,000 and an isoelectric point of 1.0 to 5.0 or a mixture containing the same is permitted to exist as the antigen-antibody reaction controller in the immunoreaction solution, and the final concentration of the antigen-antibody controller in the immunoreaction solution is controlled to 0.02 to 0.9% by weight, and a reagent kit to be used for an immunoassay containing the above antigen-antibody reaction controller at a final concentration of 0.02 to 0.9% by weight in the immunoreaction solution, as a part of the constituents thereof.

    摘要翻译: 在溶液中进行的免疫测定方法,其中允许平均分子量为16,000至50,000,等电点为1.0至5.0的蛋白质或含有该蛋白质的混合物作为免疫反应溶液中的抗原 - 抗体反应控制剂存在, 将免疫反应溶液中的抗原 - 抗体控制剂的终浓度控制在0.02〜0.9重量%,将试剂盒用于含有上述抗原 - 抗体反应控制剂的终浓度为0.02〜0.9%的免疫测定 免疫反应溶液中的重量,作为其成分的一部分。

    Quantitation of human pulmonary surfactant and reagent kit to be used
therefor
    6.
    发明授权
    Quantitation of human pulmonary surfactant and reagent kit to be used therefor 失效
    人类使用的人肺表面活性剂和试剂盒的定量

    公开(公告)号:US5156950A

    公开(公告)日:1992-10-20

    申请号:US638026

    申请日:1991-01-07

    IPC分类号: C07K16/18 G01N33/68

    摘要: A method of quantitation of human pulmonary surfactant characterized by determining the quantity of human pulmonary surfactant in the test sample according to the immunological method by use of the primary monoclonal antibodies which recognize the human pulmonary surfactant apoproteins and the labeled secondary monoclonal antibodies which recognize said apoproteins but bind to a part of the antigen which is different from the one to which the primary monoclonal antibodies bind, and a reagent kit to be used for the quantitation.

    摘要翻译: 一种定量人肺表面活性剂的方法,其特征在于根据免疫学方法通过识别人肺表面活性蛋白的首要单克隆抗体和识别所述脱辅基蛋白的标记的次级单克隆抗体来测定测试样品中人肺表面活性剂的量 但是结合到与一级单克隆抗体结合的抗原的不同部分的抗原和用于定量的试剂盒。

    Liposome immunoassay method and kit therefor
    7.
    发明授权
    Liposome immunoassay method and kit therefor 失效
    LIPOSOME免疫方法和套件

    公开(公告)号:US5173406A

    公开(公告)日:1992-12-22

    申请号:US339824

    申请日:1989-01-05

    摘要: A liposome immunoassay comprising the steps of reacting an analyte antigen, a liposome bearing antibody comprising a first antibody to the analyte antigen and a liposome encapsulating a marker therein linked to the antibody, and a second antibody to the analyte antigen to form an antigen-antibody complex, releasing the marker from the liposome in an amount depending on an amount of the analyte antigen in the presence of a complement, and measuring the released marker to determine the analyte antigen, characterized in using a third antibody capable of binding directly or indirectly to the second antibody and having an ability to activate the complement; andA kit for liposome immunoassay comprising at least one of; (1) an liposome bearing antibody comprising a first antibody to an analyte antigen and liposome encapsulating a marker therein linked to the antibody; (2) a second antibody to the analyte antigen; (3) a third antibody capable of binding directly or indirectly to the second antibody and having an ability to activate a complement; and (4) the complement.